Proton pump inhibitors and the risk of urolithiasis: A Mendelian randomization study. [PDF]
Guo J, Chen X, Dou Y, Xiong Y, Zhao T.
europepmc +1 more source
Proton pump inhibitors-induced thrombocytopenia: A systematic literature analysis of case reports. [PDF]
Yue X, Tian H.
europepmc +1 more source
Comparative Efficacy of Potassium-Competitive Acid Blockers (P-CABs) Versus Proton Pump Inhibitors (PPIs) in the Management of Erosive Esophagitis: A Systematic Review. [PDF]
Raza H +8 more
europepmc +1 more source
Pharmacokinetics of CYP2C19- and CYP3A4-Metabolized Drugs in Cirrhosis Using a Whole-Body PBPK Approach. [PDF]
Mu R +5 more
europepmc +1 more source
A Vanished Association Between Proton Pump Inhibitors and Clostridioides Difficile Infection After Minimizing Bias. [PDF]
Wu B, He Z, Xu T.
europepmc +1 more source
Tegoprazan in Gastroesophageal Reflux Disease and Related Acid-Mediated Conditions: A Systematic Review and Meta-Analysis. [PDF]
Bandyopadhyay S +4 more
europepmc +1 more source
Risk of Depression Related to Use of Proton Pump Inhibitors and Tegoprazan: A Nationwide Cohort Study. [PDF]
Kim S, Kim JS.
europepmc +1 more source
Fexuprazan for the Prevention of Nonsteroidal Anti-Inflammatory Drug-Induced Peptic Ulcer: A New Player in the Gastroprotection Landscape. [PDF]
Joo DC, Kim GH.
europepmc +1 more source
Association between proton pump inhibitor use and muscle mass: a US population-based study. [PDF]
Xiong G +7 more
europepmc +1 more source
Stability of Medications Administered via Enteral Feeding Tubes: A Systematic Review. [PDF]
Alodat L, Shahin W, Breik L, Allahham A.
europepmc +1 more source

